Application 214121
- Type
- NDA
- Sponsor
- ACCORD HLTHCARE INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | METHOTREXATE | METHOTREXATE | INJECTABLE;INJECTION | 5G/50ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N214121-001 | METHOTREXATE | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | c0c555d07b60… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N214121-001 | METHOTREXATE | 5GM/50ML (100MG/ML) | SOLUTION / INTRAVENOUS | RLD | 2020-08-24 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| METHOTREXATE | METHOTREXATE | Alembic Pharmaceuticals Limited | e98b2abd-8068-482e-9ce3-1ab262f0838e | 2026-04-16 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE METHOTREXATE |
| Methotrexate | METHOTREXATE | Golden State Medical Supply, Inc. | 6f14ced9-c16b-905a-e053-2a91aa0a031e | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | Methotrexate METHOTREXATE |
| Methotrexate | METHOTREXATE | Safecor Health LLC | f177e6fa-c482-432d-8208-937468ab3f10 | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | Methotrexate METHOTREXATE |
| Methotrexate | METHOTREXATE | AvPAK | 4992fdaa-b880-ee25-e063-6394a90af03b | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | Methotrexate METHOTREXATE |
| Methotrexate | METHOTREXATE | Chartwell RX, LLC | 2609da8f-80dc-448e-8eba-35d11488ce7f | 2025-12-17 | Boxed warning, Warnings, Adverse reactions | Methotrexate METHOTREXATE |
| Rasuvo | METHOTREXATE | Medexus Pharma Inc. | d0075461-0e7e-4967-9c9b-d6440e912c0e | 2025-12-15 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| Methotrexate | METHOTREXATE | Hospira, Inc. | 0e30eaef-5a09-4104-8a11-c32933eadeab | 2025-08-22 | Boxed warning, Warnings, Adverse reactions | Methotrexate METHOTREXATE |
| Methotrexate | METHOTREXATE SODIUM | Fresenius Kabi USA, LLC | ec476b11-0b3c-4139-b1eb-a3daa76bc271 | 2025-08-19 | Boxed warning, Warnings, Adverse reactions | Methotrexate |
| Methotrexate | METHOTREXATE | Mylan Institutional Inc. | 8df0780e-0fbd-4ab8-80b0-7a5eaa08ec0a | 2025-07-22 | Boxed warning, Warnings, Adverse reactions | Methotrexate METHOTREXATE |
| Methotrexate | METHOTREXATE | Hikma Pharmaceuticals USA Inc. | b080eb92-fc72-4ce6-a7ab-3f9ce2415526 | 2025-07-17 | Boxed warning, Warnings, Adverse reactions | Methotrexate METHOTREXATE |
| Methotrexate | METHOTREXATE | Teva Parenteral Medicines, Inc. | 346ec9ce-dc98-4a55-b55e-d3af11f2d703 | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | Methotrexate METHOTREXATE |
| METHOTREXATE | METHOTREXATE | Eugia US LLC | 63bb6fbf-dd59-4edc-af8f-d0c397ca1262 | 2025-07-10 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE METHOTREXATE |
| Methotrexate | METHOTREXATE | Hospira, Inc. | bd287e89-32f9-4396-95fa-4b562869f476 | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | Methotrexate METHOTREXATE |
| Methotrexate | METHOTREXATE | Hospira, Inc. | 0d63ba29-b692-41b4-87e8-351265c8273f | 2025-06-10 | Boxed warning, Warnings, Adverse reactions | Methotrexate METHOTREXATE |
| Methotrexate | METHOTREXATE | Coupler LLC | 2f20d43e-a4b3-a839-e063-6394a90ace38 | 2025-02-27 | Boxed warning, Warnings, Adverse reactions | Methotrexate METHOTREXATE |
| Otrexup | METHOTREXATE | Antares Pharma, Inc. | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 2025-01-31 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| Methotrexate | METHOTREXATE | NuCare Pharmaceuticals, Inc. | 2b61822e-b488-5eaf-e063-6394a90a2dcd | 2025-01-14 | Boxed warning, Warnings, Adverse reactions | Methotrexate METHOTREXATE |
| Methotrexate | METHOTREXATE | Zydus Lifesciences Limited | 59ea7b32-2b6d-4197-92c3-015936f04ebe | 2024-12-05 | Methotrexate METHOTREXATE | |
| Methotrexate | METHOTREXATE | Bryant Ranch Prepack | e6611304-4622-4b2e-9b94-57fbad023ae2 | 2024-10-01 | Boxed warning, Warnings, Adverse reactions | Methotrexate METHOTREXATE |
| Methotrexate | METHOTREXATE | Hikma Pharmaceuticals USA Inc. | 8593f7fc-eabe-44ae-bb05-b3d7d408e4f7 | 2024-09-05 | Boxed warning, Warnings, Adverse reactions | Methotrexate METHOTREXATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.